ANT-043

N/A

Report date: 2022/01/28 17:45:08

Base Information

Drug NameANT-043
Drug Alias NameAnti-HER2 antibody fragment-drug conjugate (FDC) (Antikor Biopharma)ANT-043ANT043
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAntikor Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAntikor Biopharma LtdZhuhai Essex Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A